Member Info for AngelMarbles

London Stock Exchange
Search Quotes
Search
Home › RNS › News
Regulatory Story
Company BATM Advanced Communications Ld
TIDM BVC
Headline BATM Launches Antibody Tests for COVID-19
Released 07:00 05-May-2020
Number 8843L

RNS Number : 8843L
BATM Advanced Communications Ld
05 May 2020

LEI: 213800FLQUB9J289RU66

5 May 2020



BATM Advanced Communications Limited

("BATM" or "the Group")



BATM launches Antibody Tests for COVID-19 and Commences Sale to European Countries

Shipping commenced to several customers in Europe and ramp up occurring to fulfil further orders



BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that its Adaltis subsidiary has launched ELISA Serological Test Kits that diagnose if a patient has had COVID-19 by detecting antibodies against it present in their blood.



The Adaltis Serological Tests are fully CE certified and the Group has commenced shipping initial orders to several customers in Europe. It is now ramping up production for larger quantities to fulfil further orders received from these customers.



Antibodies are proteins produced by the body in response to harmful substances called antigens (e.g. a virus). ELISA (enzyme-linked immunosorbent assay) serological tests measure the amount of various antibodies present in the blood when the body is responding to a specific infection, like COVID-19. The ELISA serological test detects the body's immune response to the infection caused by the virus rather than detecting the virus itself - to help identify those who have been infected and developed antibodies that may protect them from future infection.



Adaltis' ELISA Serological Tests for COVID-19 are designed to test for IgA and IgM (antibodies produced within approximately 4-5 days of the immune system response) as well as IgG antibodies (which are produced after a few weeks and stay present in the body for at least several months), which the Group believes enables the detection of COVID-19 antibodies at an earlier stage than with many competing tests. In addition, Adaltis' tests can be conducted both on standard ELISA machines that are already in widespread use in laboratories and hospitals, and on Adaltis' Personal LAB and NEXgen machines, which are pre-calibrated for these tests. Details of these instruments can be found on the Adaltis website: www.adaltis.com.



Adaltis' ELISA Serological Tests for COVID-19 are complementary to the Group's two previously-announced COVID-19 diagnostics kits, which are both antigen tests (RT-PCR) designed to detect the presence of the virus rather than the immune response to it. The two kits include Adaltis' diagnostic tests that are being shipped for medical facility use and the kits that the Group is developing in partnership with Novamed for home use.



The ELISA serological tests can provide important statistical infor

Kicking myself today ..i sold my shares just before this news knowing it was to come, but zvi kept saying 4months down the line..
BVC was actually the first to get on board w the antibody tests so that makes sense to be the first out ..how comes it's not in a RNS ? Ive tied my money out of bvc into another stock I believe in but have managed t buy a tiny amount at the rerated price to my dismay but its a good company so more to come . GL.all

Just throwing it out there, lol ..get our brains working

Mineralex nice post .
I'm not worried about tertiary minerals ..we are a main player in fluorspar a much needed resource and then we have gold .. bring on the results please tym

Has anyone done further research into greenwood or contacted him? He is a friend in common w Anthony Brooke in Thailand .
Greenwood know his stuff and has set up a property group in Thailand ..what could be advantageous to him for his empire in property? It could be just an investment. Commodities/precious metals is the start of a climb up imo and it's the best time for a company to list itself in the discerning investors of the London exchanges ..
Àshwath is more concentrated on North American Canadian and so this area may open up with contacts along the lines of gold and platinum.. companies based In Idaho and Montana blue gem mountain area for precious metals and sapphires would be interesting .. Brooke I think still has links with North America sapphires and the nyala mines in Malawi which could have presented. Opportunites. Brooke has retail business hotel Mgmt experience so another connection w greenwood of things in common . u could link mining in with retail opportunities that involve commercialising a tourist package with an experience finding precious metals / gems..

Falling for the tree shake ..the ones winning here is the market makers with their massive spread commission's on our trades ..one to hold for medium to long term

If it's gold , Australia , calidus expressed interest to be on a UK exchange .

https://www.calidus.com.au/

what is TMO interested in ATM?
An advert popped up for a virtual meeting event
Topics will include comprehensive genomic profiling (CGP), the future of precision oncology biomarkers testing, personal experiences with different NGS products and solutions, and much more. These discussions are CE-certified, click to learn more about the event. Join us at OncomineWorld: A virtual NGS education meeting on May 14

A I potential working way into health sectors ..so much potential for this share ..I've just bought at the height of today ..it's tech that is intelligent that links up to daily life and health .

This is next generation very state of the art reagents..as I have understood the mass spectrometry means more testing with less reagent they have devised with high accuracy , and this means testing en mass at cheaper cost with the backing of Thermofisher who has reagents and supply chain and gearing up in UK bases of alderley edge, Milton Keynes and Glasgow...John bell at uni of Oxford I think mentioned Thermofisher and the UK rollout of mass production ..PRM devised state of the art technology which is highly sensitive and accurateThe company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for prognostic and therapeutic applications.Why wouldn't u shout this out to the roof tops ..either because they want to secure the deal for themselves or not get competitors copying or for a sale being talked about . It is baffling ..u would think the company would want t generate interest and investor engagement . Keep researching everyone

Many dimensions make this a strong versatile company that is adaptable and flexible to the times. It has solutions to include
Diagnostic kits for pathogens that emerge
Diagnostic instruments
Ventilators
Waste disposal of pathogenic waste..
and this is not the end of it ..they have more feathers to their bow

That's why he mentioned they have surprises ..they r creative , innovative and come up with engineered solutions to problems we need tackling

Their bio states
We have wide experience across the life sciences sector working with many different human and animal sample types including blood plasma, CSF, solid tissues, cell culture material etc.

The need for tests won't go away ..test test test still for months t come ..more markets more countries makes the growth for this company massive for months down the line ..we r expecting announcements ..near to come early next week ..we know NCYT is the leading most accurate and has big scale up manufacturing output ..when u invest invest in the best

If it drops its people who invest who r sheep n follow those with conviction .. fickle people who r not needed..people who recognise value hold ..we know gold n Fluorspar r monster commodities and this share is looking t rise ..expecting good results ..your either in or Ur out

I'm in . Glasgow uni is a centre of excellence for emerging pathogens research n study n trials for medical and vetinary ..we also have Liverpool and London centres ..people overlook the vetinary market but there r very similar covid19 diseases in our pets currently not much understood or with potential treatment . Biomarkers are needed to get accurate treatment and medicine so this is vital in the study and development of medicines for humans and animals .#obd will be looking at biomarkers and finding the therapies ..this is amazing .. I can see this doubling ..#prm also is world leading in proteomics and very undervalued and a 10th less of obds share price .. I can see collaboration and partnership forming as they work in the lighthouse labs and promote UK as the innovative hub for life sciences it is

Get in while it's quiet .
GL for all invested

Major companies involved in the global central nervous system biomarker (CNS)

https://www.google.com/amp/s/www.bccourier.com/global-central-nervous-system-cns-biomarkers-market-with-coronavirus-covid-19-effect-analysis-likewise-industry-is-booming-globaly-with-key-players-abastar-mdx-proteome-sciences-thermo-fisher/amp/

The true hand will be revealed very soon and will have the last laugh as to who the RTO target is .

Now that would be nice !

Chill there has t be drops for new investors t enter... People r trying t profit on other high risers that's all but they may be caught out when Rld rises